Chemoinformaics analysis of Beta-elemen
Molecular Weight | 204.357 | nRot | 3 |
Heavy Atom Molecular Weight | 180.165 | nRig | 9 |
Exact Molecular Weight | 204.188 | nRing | 1 |
Solubility: LogS | -4.54 | nHRing | 0 |
Solubility: LogP | 4.998 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 41.053 |
nHD | 0 | BPOL | 24.077 |
QED | 0.582 |
Synth | 4.188 |
Natural Product Likeliness | 2.864 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.81 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.54 |
MDCK | 0.0000218 |
BBB | 0.098 |
PPB | 0.854572 |
VDSS | 2.36 |
FU | 0.128906 |
CYP1A2-inh | 0.226 |
CYP1A2-sub | 0.489 |
CYP2c19-inh | 0.273 |
CYP2c19-sub | 0.914 |
CYP2c9-inh | 0.115 |
CYP2c9-sub | 0.338 |
CYP2d6-inh | 0.207 |
CYP2d6-sub | 0.717 |
CYP3a4-inh | 0.897 |
CYP3a4-sub | 0.363 |
CL | 6.787 |
T12 | 0.086 |
hERG | 0.042 |
Ames | 0.006 |
ROA | 0.086 |
SkinSen | 0.225 |
Carcinogencity | 0.515 |
EI | 0.981 |
Respiratory | 0.216 |
NR-Aromatase | 0.031 |
Antiviral | Yes |
Prediction | 0.78259 |